The journal CHEST has received an increased journal Impact Factor of 10.262 up from its 2020 score of 9.410.
The journal CHEST is the official publication of the American College of Chest Physicians®. The journal continues to rank 6th out of 65 journals in the Respiratory System category and has the highest readership of any journal in the fields of critical care and pulmonary.
A proprietary measure owned and issued by Clarivate Analytics, the Impact Factor is an assessment of a journal’s quality based on the number of article citations. In the 2021 review period, the journal CHEST had 656 citable items that were cited 6,732 times.
With an acceptance rate for original research averaging 8%, the journal is a leading source of peer-reviewed, cutting-edge original research in the multidisciplinary specialties of chest medicine: pulmonary, critical care and sleep medicine and related disciplines. It is home to highly regarded clinical practice guidelines and consensus statements that resonate with a broad audience of medical professionals. The journal CHEST continues to hold the highest independent readership scores among the hospital-based professionals most directly served by the clinical research published in the journal based on an independent study from a leading research firm.
Set to launch in early 2023, the new journals, CHEST Pulmonary and CHEST Critical Care, will contain specialized research in the fields of pulmonary, sleep and critical care medicine and will only include content that is open access to all readers.
Similar to the journal CHEST, CHEST Pulmonary and CHEST Critical Care will accept submissions of original research, reviews, and case reports, with enhanced emphasis on medical decision-making, implementation science, health services delivery, quality improvement, cost-effectiveness analysis, policy reports, study design and more.